Biotic and abiotic determinants of ser oprevalence of antibodies a gainst Trypanosoma cruzi in Palmar de Bravo, Puebla, Mexico

Francisca Sosa-Jurado; José Lino Zumaquero-Ríos; Pedro A Reyes; Abel Cruz-García; Carmen Guzmán-Bracho; Víctor M Monteón

2004, Number 1

<< Back Next >>

salud publica mex 2004; 46 (1)

**Biotic and abiotic determinants of ser oprevalence of antibodies a gainst Trypanosoma cruzi in Palmar de Bravo, Puebla, Mexico**

Sosa-Jurado F, Zumaquero-Ríos JL, Reyes PA, Cruz-García A, Guzmán-Bracho C, Monteón VM

Full text

How to cite this article

Language: Spanish
References: 27
Page: 39-48
PDF size: 79.63 Kb.

ABSTRACT

Objective. To establish the relationship between seroprevalence for antibodies against Trypanosoma cruzi and its relationship with biotic and abiotic factors. Material and Methods. A cross-sectional study was conducted between August 2000 and September 2001. The study population consisted of a simple random sample of 390 volunteers residing in Palmar de Bravo, Puebla, Mexico. Sample and data collection procedures included assaying antibodies against T cruzi with validated assays, and searching for domestic reservoirs and triatomine bugs. The relationship between biotic and abiotic factors with seropositivity was assessed. Statistical analysis was conducted using Kappa values for diagnostic tests; statistical significance was assessed with 2 x 2 tables, chi-squared test with Yates’ correction, Fisher exact test, and odds ratios. Results. The seroprevalence of T cruzi infection in humans was 4%; in domestic reservoirs (horses, pigs, and dogs) only 10% of canine reservoirs were positive. Vector species recognized were T barberi and T pallidipennis, with a Dispersion Area Index and a Colonization Index of 55% and 40%, respectively. The most important risk factors associated with positive serology were altitude (›2 150 y ‹2 180 meters above sea level), presence of triatomines, age, time of residence, and participation in a social assistance program. Conclusions. T cruzi infection was identified in human beings, vectors, and possibly in domestic reservoirs, in communities located over 2 000 meters above sea level.

REFERENCES

Acha P, Szyfres-Boris. Zoonosis y enfermedades transmisibles al hombre y a los animales: enfermedad de Chagas. Washington, DC: OPS/ OMS, 1992: 590-601.
Pinto-Días JC, Wendel S, Brener Z, Camargo ME, Rassi A. Epidemiology of Chagas disease. Sao Paulo: Ed ISBT, 1992:1-5.
Guzmán-Bracho C. Epidemiology of Chagas disease in México:An update. Trends Parasitol 2001; 17:372-376.
Zárate LG, Zárate RA. Checklist of the Traiatominae (Hemiptera:Reduviidae) of Mexico. Int J Entomol 1985; 27:102-127.
Vidal-Acosta V, Ibáñez-Bernal S, Martínez-Campos C. Infección natural de chinches Tratominae con Trypanosoma cruzi asociadas a la vivienda humana en México. Salud Publica Mex 2000; 42(6):496-503.
Gurtler RE, Céceres MC, Rubel DN, Petersen RM, Schweigman NI, Lauricella Ma et al. Chagas disease in north-west Argentina: Infected dogs as a risk factor for the domestic transmission of Trypanosoma cruzi. Trans R Soc Trop Med Hyg 1991; 85:741-745.
Wendel S, Brener Z, Camargo ME, Rassi A. Chagas disease (American trypanosomiasis): Its impact on transfusion and clinical medicine. Sao Paulo, Ed. ISBT; 1992:1-3.
Guzmán-Bracho C, García-García L, Florián-Verdugo J, Guerrero-Martínez S, Torres-Cosme M, Ramírez-Melgarejo et al. Riesgos de transmisión de T cruzi por transfusión de sangre. Rev Panam Salud Pública 1998; 4(2):590-601.
Monteón-Padilla VM, Hernández-Becerril N, Guzmán-Bracho C, Rosales-Encinas JL, Reyes-López PA. American tripanosomiasis (Chagas disease) and blood banking in Mexico City: Seroprevalence and its potential transfusional transmission risk. Arch Med Res 1999; 30:393-398.
Camargo ME, Segura EL, Kagan IG, Pacheco-Souza JM, Carvalheiro JR, Yanovsky JF. Normalización del diagnóstico serológico de la enfermedad de Chagas en Las Américas: evaluación de tres años de colaboración. Bol Oficina Sanit Panam 1987;102(5):449-463.
Secretaria de Salud. PROY-NOM-032-SSA2-2000. Para la vigilancia, prevención y control de enfermedades transmitidas por vector. México DF: Diario Oficial de la Federación, 21 Nov 2000. 2a sección.
Salazar-Schettino PM, Tay ZJ, Ruiz-Hernández AL, De Haro CI, Jiménez J, García-Yáñez Y et al. Seropositividad a Trypanosoma cruzi en cuatro grupos de población del estado de Oaxaca. Salud Publica Mex 1984; 26(6):589-595.
Ruegger-Gutiérrez L, Monteón-Padilla VM, Marcuschamer J, Reyes López PA. Tripanosomiasis americana (enfermedad de Chagas) encuesta clínico-serológica en un municipio rural oaxaqueño. Arch Inst CardiolMex 1993; 63:341-346.
Pérez-Fuentes R, Sánchez-Guillén MC, González-Alvarez C, Monteón-Padilla VM, Reyes-López PA, Rosales-Encinas JL. Humoral nitric oxide levels and antibody immune response of symptomatic an indeterminate Chagas disease patients to commercial and autochthonous Trypanosoma cruzi antigen. Am Soc Trop Med Hyg 1998;58(6):715 –720.
Velasco-Castrejón O, Valdespino JL, Tapia-Conyer R, Salvatierra B, Guzmán-Bracho MC, Magos C et al. Seroepidemiología de la enfermedad de Chagas en México. Salud Publica Mex 1991; 34(2):186-196.
Monteón-Padilla VM, Sosa T, Reyes-López PA. Serological test for American trypanosomiasis: A comparative study. Rev Lat Microbiol Mex 989; 31:35-38.
Guzmán BC, Floriani VJ, Guerrero MS, Ramírez NA, Hernández MG, Cuauhtécatl HA. Manual de procedimientos de laboratorio del InDRE:diagnóstico de laboratorio de la enfermedad de Chagas. México, DF:InDRE, SSA, 1999:19-37.
Lent H, Wigodzinsky P. Revision of the triatominae (Hemiptera: Reduviidae), and their significance as vector of Chagas disease. Bull Am Mus Nat Hist 1979; 163:124-520.
Sistema Estatal de Protección Civil, Instituto Nacional de Estadística, Geografía e Informática. Información Nomenclátor para el estado de Puebla. Localidades, instalaciones diversas, orografía, hidrografía y formas costeras y marítimas. México, DF: INEGI,1995.
Frenk MJ, Lozano R. Observatorio de la salud: necesidades, servicios y políticas. México DF; Ed Fundación México para la Salud, 1997:28-31.
Pineault R, Daveluy C. La planificación sanitaria: conceptos, métodos, estrategias. 2a ed. Madrid: Masson, 1994:236-239.
Velasco-Castrejón O, Ramírez J, Sánchez B, Trujillo F, Guzmán BC. La enfermedad de Chagas en Jalisco, México. Rev Mex Parasitol 1989; 2:29-32.
Monteón PVM, Guzmán BC, Floriani VJ, Ramos EA, Velasco CO, Reyes LPA. Diagnóstico serológico de la enfermedad de Chagas:autosuficiencia y concordancia interlaboratorios. Salud Publica Mex 1995; 37(3): 232-235.
Vallejo AM, Reyes-López PA. La Trypanosomosis americana ¿Un problema socio médico en México? Arch Inst Cardiol Mex 1996;66:95-97.
Solís-Franco RR, Romo-Zapata JA, Martínez-Ibarra A. Wild reservoirs infected by Trypanosoma cruzi in the Ecological Park “El Zapotal” Tuxtla Gutiérrez, Chiapas, México. Mem Inst Oswaldo Cruz 1997; 92(2):163-164.
Gurtler RE, Petersen RM, Lauricella MA, Wisnivesky-Colli C. Infectivity to the vector Triatoma infestans of dogs infected with Trypanosoma cruzi in north-west Argentina. Ann Trop Med Parasitol 1992; 86(2):111-119.
Monteón-Padilla VM, Ramos EA, Reyes-López PA. Reactividad de sueros de pacientes chagásicos crónicos con extractos de aislamientos mexicanos de Trypanosoma cruzi. Rev Biol Trop 1993; 41(3):861-865.